HA1004, an intracellular calcium antagonist, selectively attenuates pulmonary hypertension in newborn lambs.

Crowley, M R; Fineman, J R; Soifer, S J

Crowley, M R; Fineman, J R; Soifer, S J.

Affiliation

Crowley MR; Cardiovascular Research Institute, University of California at San Francisco, 94143.

J Cardiovasc Pharmacol ; 23(5): 806-13, 1994 May.

Article in En | MEDLINE | ID: mdl-7521465

Subject(s)

Calcium Channel Blockers/therapeutic use; Hemodynamics/drug effects; Hypertension, Pulmonary/drug therapy; Isoquinolines/therapeutic use; Protein Kinase Inhibitors; Sulfonamides; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Animals, Newborn; Calcium Channel Blockers/pharmacology; Hypertension, Pulmonary/etiology; Hypertension, Pulmonary/physiopathology; Hypoxia; Infusions, Intravenous; Isoquinolines/pharmacology; Muscle Relaxation/drug effects; Nifedipine/pharmacology; Prostaglandin Endoperoxides, Synthetic; Pulmonary Alveoli; Regression Analysis; Sheep; Thromboxane A2/analogs & derivatives

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Calcium Channel Blockers / Protein Kinase Inhibitors / Hemodynamics / Hypertension, Pulmonary / Isoquinolines Type of study: Diagnostic_studies / Etiology_studies Limits: Animals Language: En Journal: J Cardiovasc Pharmacol Year: 1994 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links